{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:00:36Z","timestamp":1790215236026,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002661","name":"FRS-FNRS","doi-asserted-by":"publisher","award":["PC01120F"],"award-info":[{"award-number":["PC01120F"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jconrel.2026.115247","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:25:02Z","timestamp":1786749902000},"page":"115247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Formation of a pulmonary drug-depot by a double-ester treprostinil prodrug enables sustained lung-selective delivery"],"prefix":"10.1016","volume":"398","author":[{"given":"Giuditta","family":"Leone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouam\u00e9 Kan Firmin","family":"Akoumia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ucakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrag","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Fr\u00e9d\u00e9rick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Dessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Vanbever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115247_bb0005","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2026.115247_bb0010","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/CIRCRESAHA.122.320084","article-title":"New mutations and pathogenesis of pulmonary hypertension: progress and puzzles in disease pathogenesis","volume":"130","author":"Aldred","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2026.115247_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000137","article-title":"Pathophysiology and new advances in pulmonary hypertension","volume":"2","author":"Bousseau","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.jconrel.2026.115247_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12137","article-title":"The evolution of survival of pulmonary arterial hypertension over 15 years","volume":"12","author":"Hendriks","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jconrel.2026.115247_bb0025","article-title":"Additional use of prostacyclin analogs in patients with pulmonary arterial hypertension: a meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115247_bb0030","article-title":"Prostacyclin for pulmonary arterial hypertension","volume":"5","author":"Barnes","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2026.115247_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2018.06.003","article-title":"Inhalation of repurposed drugs to treat pulmonary hypertension","volume":"133","author":"Gessler","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115247_bb0040","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s40262-016-0409-0","article-title":"A comprehensive review of Treprostinil pharmacokinetics via four routes of administration","volume":"55","author":"Kumar","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2026.115247_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/DDDT.S19281","article-title":"Inhaled treprostinil: a therapeutic review","volume":"6","author":"Channick","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2026.115247_bb0050","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1152\/japplphysiol.00083.2005","article-title":"Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation","volume":"99","author":"Sandifer","year":"2005","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.jconrel.2026.115247_bb0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pupt.2018.02.002","article-title":"Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil","volume":"49","author":"Chapman","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115247_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12016","article-title":"Real-world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting","volume":"12","author":"Balasubramanian","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jconrel.2026.115247_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115247_bb0070","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","article-title":"Lipophilicity and its relationship with passive drug permeation","volume":"28","author":"Liu","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115247_bb0075","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.apsb.2021.05.015","article-title":"Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines","volume":"11","author":"Guo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115247_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2013.07.023","article-title":"Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung","volume":"171","author":"Bayard","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115247_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2016.08.008","article-title":"PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma","volume":"239","author":"Luo","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115247_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10600","article-title":"PEGylated therapeutics in the clinic","volume":"9","author":"Gao","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115247_bb0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/acsbiomedchemau.4c00042","article-title":"Antigenicity extension: a novel concept explained by the immunogenicity of PEG","volume":"5","author":"Shiraishi","year":"2025","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.jconrel.2026.115247_bb0100","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1021\/acs.chemrev.8b00006","article-title":"Designing smart polymer conjugates for controlled release of payloads","volume":"118","author":"Seidi","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115247_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107287","article-title":"Synthesis and in vitro evaluation of polyethylene glycol-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension","volume":"214","author":"Leone","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115247_bb0110","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/mol.62.5.1103","article-title":"Pharmacophore definition and three-dimensional quantitative structure-activity relationship study on structurally diverse prostacyclin receptor agonists","volume":"62","author":"Stoll","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115247_bb0115","series-title":"US 11,826,328 B2, United States","article-title":"Stable treprostinil prodrugs","author":"Phares","year":"2023"},{"key":"10.1016\/j.jconrel.2026.115247_bb0120","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1016\/j.bmcl.2008.07.058","article-title":"Studies on the porcine liver esterase-catalyzed hydrolysis of pentaacetyl catechin and epicatechin: application to the synthesis of novel dimers and trimers","volume":"18","author":"Basak","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115247_bb0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijpharm.2013.05.027","article-title":"Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives","volume":"454","author":"Arpicco","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115247_bb0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-3659(00)00362-X","article-title":"Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance","volume":"70","author":"Bosquillon","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115247_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17040436","article-title":"Comprehensive aerodynamic and physicochemical stability evaluations of nanocrystal-based dry powder inhalers: the role of mannitol and leucine in enhancing performance","volume":"17","author":"Banat","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115247_bb0140","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3390\/pharmaceutics14112324","article-title":"Drug stability: ICH versus accelerated predictive stability studies","volume":"14","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115247_bb0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1208\/s12249-021-02121-8","article-title":"Accelerated stability assessment program to predict long-term stability of drugs: application to ascorbic acid and to a cyclic hexapeptide","volume":"22","author":"Legrand","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115247_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082372","article-title":"Prostanoid EP(2) receptors are up-regulated in human pulmonary arterial hypertension: a key anti-proliferative target for Treprostinil in smooth muscle cells","volume":"19","author":"Patel","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115247_bb0155","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41598-018-19294-1","article-title":"Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation","volume":"8","author":"Lambers","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115247_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1165\/ajrcmb.26.2.4695","article-title":"Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery","volume":"26","author":"Clapp","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.115247_bb0165","article-title":"Comprehensive echocardiographic assessment of right ventricle function in a rat model of pulmonary arterial hypertension","volume":"191","author":"Rosas","year":"2023","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2026.115247_bb0170","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v5i1.1332","article-title":"Probiotics-derived butyric acid may suppress systemic inflammation in a murine model of chronic obstructive pulmonary disease (COPD)","volume":"5","author":"Pradana","year":"2025","journal-title":"Narra J"},{"key":"10.1016\/j.jconrel.2026.115247_bb0175","first-page":"5144","article-title":"Safety, tolerability, and pharmacokinetics of Treprostinil Palmitil inhalation powder for pulmonary hypertension: a phase 1, randomized, double-blind, single- and multiple-dose study","volume":"39","author":"Ismat","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2026.115247_bb0180","series-title":"Elemental Impurities","author":"Q.D.R. European Medicines Agency","year":"2019"},{"key":"10.1016\/j.jconrel.2026.115247_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2021.101497","article-title":"Natural and bioinspired excipients for dry powder inhalation formulations","volume":"56","author":"Zillen","year":"2021","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.115247_bb0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/pr.56.1.3","article-title":"Enzyme-catalyzed activation of anticancer prodrugs","volume":"56","author":"Rooseboom","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2026.115247_bb0195","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/acs.molpharmaceut.6b00908","article-title":"In vitro and in silico tools to assess extent of cellular uptake and lysosomal sequestration of respiratory drugs in human alveolar macrophages","volume":"14","author":"Ufuk","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115247_bb0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.112.197152","article-title":"Differential effects of Selexipag [corrected] and prostacyclin analogs in rat pulmonary artery","volume":"343","author":"Morrison","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.115247_bb0205","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/01.CIR.102.16.2005","article-title":"Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2026.115247_bb0210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/HYPERTENSIONAHA.107.091348","article-title":"Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats","volume":"50","author":"Ito","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2026.115247_bb0215","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0008-6363(95)00108-5","article-title":"Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats","volume":"30","author":"Mathew","year":"1995","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2026.115247_bb0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vph.2012.07.006","article-title":"Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-alpha antagonists via the suppression of TNF-alpha expression and NF-kappaB pathway in rats","volume":"58","author":"Wang","year":"2013","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115247_bb0225","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/10641963.2012.721838","article-title":"Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension","volume":"35","author":"Sirmagul","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.jconrel.2026.115247_bb0230","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/rccm.201607-1515PP","article-title":"Translating research into improved patient care in pulmonary arterial hypertension","volume":"195","author":"Bonnet","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:59:13Z","timestamp":1790211553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0168365926006516"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115247","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formation of a pulmonary drug-depot by a double-ester treprostinil prodrug enables sustained lung-selective delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115247"}}